drugset / Trial / NCT02933658

Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers

NCT02933658

Phase 1 Completed 71 enrolled Daewon Pharmaceutical Co., Ltd.
Non-randomizedCrossoverOpen-labelTreatment

Summary

A non-randomized, two-arm, single-sequence, crossover, open label, multiple oral dosing clinical trial to evaluate the safety and the pharmacokinetic drug-drug interaction of Telmisartan/Amlodipine and Rosuvastatin in healthy male volunteers

Timeline

Start
2015-11
Primary completion
2015-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified
Subject Rosuvastatin Small molecule
Subject Telmisartan Other / unclassified

Indications

No indication recorded.